Synapse Open Synapse
Biology

GLP-1 compounder issues recall for copycat Zepbound

BioPharma Dive · · 1 min read

The notice adds to growing concerns about the safety of knockoff weight loss drugs, which have remained popular despite FDA warnings and legal pressure from Eli Lilly and Novo.

Latest from BioPharma Dive